PaceMate, LLC

Biocynetic, Inc. is a Florida-based technology firm specializing in advanced cardiac remote monitoring solutions for healthcare providers, enhancing workflow efficiency and patient data management. Founded in 2015 in Bradenton, Florida, Biocynetic, Inc. operates in the cardiac monitoring space, focusing on remote solutions.

The company has closed 2 deals to date, with the most recent funding round being a Series A in July 2023, raising USD 8. 00 mn led by Ballast Point Ventures. The founder, Jason Hale, has a background in technology and healthcare innovation. PaceMate® provides PaceMateLIVE, a comprehensive cardiac remote monitoring solution that integrates data from various cardiac devices and electronic health records.

This platform enhances clinician workflows by enabling intelligent patient prioritization and efficient data processing, significantly reducing delays in patient care. Key features include one-click report signing and batch processing capabilities. Clients range from individual clinics to major healthcare systems like Ascension Sacred Heart and Duke Lifepoint Healthcare, marking a strong presence across the U. S.

healthcare landscape. PaceMate's revenue model is primarily subscription-based, offering various service tiers for its software, PaceMateLIVE. The company engages in B2B transactions, tailoring services to meet the specific needs of healthcare providers, which include both self-managed and fully supported solutions. Clients typically enter service agreements, paying for software access and additional support as needed, catering to a diverse range of healthcare organizations.

Following the recent funding round in July 2023, Biocynetic, Inc. plans to utilize the raised capital to support its business expansion efforts. The company is focusing on designing new products aimed at enhancing its monitoring solutions, while also targeting geographic expansion into previously untapped markets to broaden its reach. Specific details on upcoming product launches and targeted regions are to be outlined in their future strategic plans.